Australia

Ross was engaged by the NSW DPI to estimate the economic impact of feral deer in Australia. 

Health Technology Assessment (HTA) dossiers submitted for local reimbursement and pricing decisions to the Australian Pharmaceutical Benefits Advisory Committee (PBAC) were evaluated in collaboration with a cross-functional team. The clinical and economic evidence presented in the submissions was analyzed.

Data was obtained to estimate the costs associated with general practitioner (GP) shared care and specialist-led models. Various elements of care delivery for patients receiving shared and specialist-led care were described. Markov and financial budget impact models were constructed in Excel to analyze the economic implications of  care approaches. Costs were estimated from the perspectives of patients, service providers, and the government. Additionally, scenarios were developed to explore the potential national cost impacts of different relative uses of shared care versus specialist-led models, informing future healthcare planning and policy decisions

Economic evaluation of Australian forest and wood-product industry research. 

Ross was a member of the University of Sydney's high risk human research ethics committee for seven years which reviews randomised clinical trial and observational research protocols to protect the mental and physical welfare, rights, dignity, and safety of human participants of research and the safety of those conducting research

Gastrointestinal Endoscopic Mucosal Resection (EMR) is a procedure used to remove early-stage cancers and precancerous growths from the digestive tract lining.  It is considered a less invasive alternative to surgery for conditions like Barrett's esophagus and colorectal cancer. The Medicare Benefits Schedule Review Taskforce proposed new funding options for EMR, emphasizing its safety, effectiveness, and potential benefits over traditional surgery. A Markov model and budget impact analysis was undertaken prior to listing of the procedure on the MBS

Formulated optimal cost pathways for mental health treatment using Markov modelling. Pathways were developed for Anxiety, Anorexia, PTSD, PND, Bipolar Disorder, and Schizophrenia for the National Mental Health Commission in Australia

The overall aim of this research project was to identify which needle syringe program (NSP) service delivery model is most effective in improving the health and wellbeing of people who inject drugs, with specific reference to hepatitis C. Key models investigated in the report included vending machines, secondary outlets and primary fixed outlets in northern, southern and lower mid north coast regions of NSW. Costs were specified for staff, goods and services and managed; and presented on unit cost basis

Deep brain stimulation delivers electrical impulses to a key central location deep in the brain, suppressing the bursts of epileptic discharges that characterise seizures. Ross was contracted to undertake economic modelling and budget impact assessment for MSAC assessment.

Estimated the national costs of control and lost production in agriculture due to weeds in Australia. Considered the RD&E options outlined in the draft Ten-Year CISS Weeds Investment Plan and provided best estimates of the returns on investment for each of the domains and for investment in the plan overall. Report available

On website https://invasives.com.au/our-publications/,

In media https://www.theland.com.au/story/5897032/weeds-cost-farmers-48-billion-per-yearnew-report/

Calculated annual drug expenditure in 2010 by the Federal Government and state and territory governments for prevention - school based, general prevention, treatment – pharmacotherapy, correctional treatment, drug diversion, harm reduction and law enforcement

Cost-benefit models were developed, and a report was prepared to document the economic evaluation of projects within the research center’s portfolio. This evaluation focused on four key elements: developing more cost-effective tools and systems for disease detection and surveillance; transferring knowledge and technologies to public health, environmental, and community sectors by enhancing national and international collaborative linkages and networks within Australia and the Asia-Pacific region; and equipping researchers, professionals, and community members with the necessary knowledge and skills to respond effectively to emerging infectious disease threats. The report provided insights into the economic implications of these initiatives